Vivli AMR Register
Publications
Researchers have used data from the Vivli AMR Register in 36 publications, including peer-reviewed articles, preprints, and theses. Each title links to the full publication.
36
publications since 2023
31
from AMR Data Challenge research
15
published in 2026
Publications by year
202615
202511
20248
20232
All publications
Showing 36 of 36 publications
2026 15 publications
- A comprehensive AMR genotype–phenotype database (CABBAGE)Data from: Pfizer
- Advancing monitoring of antimicrobial resistance trajectories using flexible spatiotemporal modelling: a change-point analysisData from: Pfizer
- AMROrbit: a trajectory-based scorecard for antimicrobial stewardship using routine susceptibility testing dataData from: Pfizer
- Childhood Antimicrobial Resistance With Global ForecastsData from: Pfizer
- Country-Level Variation in Acinetobacter baumannii Resistance across North America, Central America, and the Caribbean: A Phenotypic and Plasmid Genomic Analysis of ATLAS Surveillance Data, 2000–2021Data from: Pfizer
- Distribution of extended spectrum beta-lactamase antibiotic resistance in Africa 2005-2021Data from: Pfizer
- Exploring the evolution of multidrug resistance patterns in ESKAPEE pathogens using association mining: Key to antibiotic stewardship?Data from: Pfizer, Venatorx Pharmaceuticals
- Factors associated with methicillin resistance in Staphylococcus aureus: a case-case-control analysis of AMR surveillance dataData from: Pfizer
- Integrating GIS and Genomics for AMR One Health Drug Target Discovery in Imipenem-Resistant Escherichia coliData from: Pfizer
- Prioritization of antimicrobial resistance surveillance of gram-negative pathogens: a stacked modelling approachData from: Pfizer
- Surveillance-Driven Machine Learning for Prediction of Antimicrobial Susceptibility: An Explainable Modeling Framework using the Pfizer ATLAS Dataset (2004–2023)Data from: Pfizer
- Temporal links between ambient air pollutants and antifungal resistance dynamics in Candida glabrata: Insights from the Vivli AMR data challengeData from: Pfizer
- Ten-Year Evolution of Voriconazole Susceptibility in Aspergillus fumigatus: A Multicenter Analysis of the VIVLI/SENTRY Antifungal Surveillance Platform (2010–2020)Data from: Pfizer
- Ten-Year Voriconazole Susceptibility Trends Among 1482 Clinical Aspergillus fumigatus Isolates: A Compositionally Controlled Multicenter Analysis of the VIVLI/SENTRY Platform (2010–2020)Data from: Pfizer
- Using GIS Dashboards to highlight AMR data disparities in Africa for Policy, Research, and Public HealthData from: GSK, Johnson & Johnson, Pfizer, Shionogi, Venatorx Pharmaceuticals
2025 11 publications
- AMROrbit: Reimagining AMR Stewardship through an Open Source, Dynamic, Actionable Scorecard from Routine Microbiology DataData from: Pfizer
- Application of statistical and machine learning methods to predict antimicrobial susceptibility to blood borne microorganisms to support administrative and policy level decision makingData from: Pfizer
- Country-level heterogeneity in MDR-TB drug susceptibility supports country-specific policy developmentData from: Johnson & Johnson
- Distribution of beta-lactamase genes in Enterobacteriaceae from human clinical samplesData from: Pfizer
- Empowering Global AMR Research Community: Interactive GIS dashboards for AMR data analysis and informed decision-makingData from: Pfizer
- Epidemiological Distributions of Beta-lactamase Genes in Enterobacteriaceae at One Health Interface in the United StatesData from: Pfizer
- Global distribution and incidence of multidrug resistant and ESBL producing Escherichia coli: an observational study of the ATLAS datasetData from: Pfizer
- Global Prediction of Antimicrobial Resistance Trends Using Statistical and Machine Learning Models: Evaluating National Action Plan Policy Impacts Through Interrupted Time Series AnalysisData from: Pfizer
- MicroBIS: An integrated AI laboratory assistant for Bacteria and Antimicrobial Resistance IdentificationData from: Pfizer
- Prediction of antibiotic resistance from antibiotic susceptibility testing results from surveillance data using machine learningData from: Pfizer
- Supervised Learning Model Systems to Predict and Identify Drivers of AMR in AfricaData from: Pfizer
2024 8 publications
- A predictive algorithm for the analysis of AMR trends and healthcare decision supportData from: Pfizer
- Antibiotic susceptibility trend estimation for India based on 2018 to 2021 data from GEARS programData from: Venatorx Pharmaceuticals
- AntiMicro.ai: an artificial intelligence powered web application for predicting antibacterial/antifungal susceptibility and constructing personalized machine learning modelsData from: Pfizer
- bla SED-1 beta-lactamase-producing Citrobacter sedlakii isolated from horses and genomic comparison with human-derived isolatesData from: Pfizer
- Colistin Sparing Strategies to Overcome Resistance: Can We Save Future!Data from: Pfizer
- Investigating the feasibility and potential of combining industry AMR monitoring systems: a comparison with WHO GLASSData from: GSK, Johnson & Johnson, Paratek Pharmaceuticals, Pfizer, Shionogi, Venatorx Pharmaceuticals
- MIC distribution analysis identifies differences in AMR between population sub-groupsData from: GSK, Paratek Pharmaceuticals, Pfizer, Venatorx Pharmaceuticals
- Predictive Modeling of Phenotypic Antimicrobial Susceptibility of Selected Beta-Lactam Antimicrobials from Beta-Lactamase Resistance GenesData from: Pfizer
2023 2 publications
- Global Geographic Patterns and Trends of WHO Priority Pathogens and AWaRe Antibiotic Resistance among Children: An Epidemiological Surveillance StudyData from: Pfizer
- Investigating the evolution and predicting the future outlook of antimicrobial resistance in sub-Saharan Africa using phenotypic data for Klebsiella pneumoniae: a 12-year analysisData from: Pfizer
Did you publish research using AMR Register data and don’t see it here? Contact us and we will add it.
Last updated November 2026.

